Literature DB >> 26780310

CXCR4 and CXCR7 Mediate TFF3-Induced Cell Migration Independently From the ERK1/2 Signaling Pathway.

Julia Dieckow1, Wolfgang Brandt2, Kirsten Hattermann3, Stefan Schob4, Ute Schulze5, Rolf Mentlein3, Philipp Ackermann6, Saadettin Sel7, Friedrich P Paulsen8.   

Abstract

PURPOSE: Trefoil factor family (TFF) peptides, and in particular TFF3, are characteristic secretory products of mucous epithelia that promote antiapoptosis, epithelial migration, restitution, and wound healing. For a long time, a receptor for TFF3 had not yet been identified. However, the chemokine receptor CXCR4 has been described as a low affinity receptor for TFF2. Additionally, CXCR7, which is able to heterodimerize with CXCR4, has also been discussed as a potential TFF2 receptor. Since there are distinct structural similarities between the three known TFF peptides, this study evaluated whether CXCR4 and CXCR7 may also act as putative TFF3 receptors.
METHODS: We evaluated the expression of both CXCR4 and CXCR7 in samples of human ocular surface tissues and cell lines, using RT-PCR, immunohistochemistry, and Western blot analysis. Furthermore, we studied possible binding interactions between TFF3 and the receptor proteins in an x-ray structure-based modeling system. Functional studies of TFF3-CXCR4/CXCR7 interaction were accomplished by cell culture-based migration assays, flow cytometry, and evaluation of activation of the mitogen-activated protein (MAP) kinase signaling cascade.
RESULTS: We detected both receptors at mRNA and protein level in all analyzed ocular surface tissues, and in lesser amount in ocular surface cell lines. X-ray structure-based modeling revealed CXCR4 and CXCR7 dimers as possible binding partners to TFF3. Cell culture-based assays revealed enhanced cell migration under TFF3 stimulation in a conjunctival epithelial cell line, which was completely suppressed by blocking CXCR4 and/or CXCR7. Flow cytometry showed increased proliferation rates after TFF3 treatment, while blocking both receptors had no effect on this increase. Trefoil factor family 3 also activated the MAP kinase signaling cascade independently from receptor activity.
CONCLUSIONS: Dimers CXCR4 and CXCR7 are involved in TFF3-dependent activation of cell migration, but not cell proliferation. The ERK1/2 pathway is activated in the process, but not influenced by CXCR4 or CXCR7. These results implicate a dependence of TFF3 activity as to cell migration on the chemokine receptors CXCR4 and CXCR7 at the ocular surface.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26780310     DOI: 10.1167/iovs.15-18129

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  27 in total

Review 1.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

Review 2.  Trefoil Factor Family: A Troika for Lung Repair and Regeneration.

Authors:  Heather L Rossi; Jorge F Ortiz-Carpena; Devon Tucker; Andrew E Vaughan; Nilam S Mangalmurti; Noam A Cohen; De'Broski R Herbert
Journal:  Am J Respir Cell Mol Biol       Date:  2022-03       Impact factor: 6.914

3.  Monomerization of Homodimeric Trefoil Factor 3 (TFF3) by an Aminonitrile Compound Inhibits TFF3-Dependent Cancer Cell Survival.

Authors:  Vijay Pandey; Xi Zhang; Han-Ming Poh; Baocheng Wang; Dukanya Dukanya; Lan Ma; Zhinan Yin; Andreas Bender; Ganga Periyasamy; Tao Zhu; Kanchugarakoppal S Rangappa; Basappa Basappa; Peter E Lobie
Journal:  ACS Pharmacol Transl Sci       Date:  2022-08-17

Review 4.  Gut homeostasis, injury, and healing: New therapeutic targets.

Authors:  Sema Oncel; Marc D Basson
Journal:  World J Gastroenterol       Date:  2022-05-07       Impact factor: 5.374

5.  Forced Trefoil Factor Family Peptide 3 (TFF3) Expression Reduces Growth, Viability, and Tumorigenicity of Human Retinoblastoma Cell Lines.

Authors:  Jan Große-Kreul; Maike Busch; Claudia Winter; Stefanie Pikos; Harald Stephan; Nicole Dünker
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

Review 6.  Trefoil Factor Family: Unresolved Questions and Clinical Perspectives.

Authors:  Nayara Braga Emidio; Werner Hoffmann; Stuart M Brierley; Markus Muttenthaler
Journal:  Trends Biochem Sci       Date:  2019-02-18       Impact factor: 13.807

Review 7.  Trefoil Factor Family (TFF) Peptides and Their Links to Inflammation: A Re-evaluation and New Medical Perspectives.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

8.  Trefoil Factor 1 Suppresses Epithelial-mesenchymal Transition through Inhibition of TGF-beta Signaling in Gastric Cancer Cells.

Authors:  Da-Young Lee; Moon-Young Song; Eun-Hee Kim
Journal:  J Cancer Prev       Date:  2021-06-30

9.  Chemical Synthesis of TFF3 Reveals Novel Mechanistic Insights and a Gut-Stable Metabolite.

Authors:  Nayara Braga Emidio; Rajeshwari Meli; Hue N T Tran; Hayeon Baik; Séverine Morisset-Lopez; Alysha G Elliott; Mark A T Blaskovich; Sabrina Spiller; Annette G Beck-Sickinger; Christina I Schroeder; Markus Muttenthaler
Journal:  J Med Chem       Date:  2021-06-18       Impact factor: 7.446

10.  Obstructive sleep apnea and rhonchopathy are associated with downregulation of trefoil factor family peptide 3 (TFF3)-Implications of changes in oral mucus composition.

Authors:  Regina Siber-Hoogeboom; Martin Schicht; Sebastian Hoogeboom; Friedrich Paulsen; Maximilian Traxdorf
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.